Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2015

Every FDA drug recall initiated in 2015, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,733 recalls, newest first.

Class II · Moderate risk

Testosterone Cypionate 200 mcg/mL in Sesame Oil Injection

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-328-2016
Class II · Moderate risk

Testosterone Cypionate 50 mg/mL Injection

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-327-2016
Class II · Moderate risk

sermorelin 1000 mcg/mL / LIDO 0.2% Injection

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-326-2016
Class II · Moderate risk

Sermorelin 1000 mcg/mL SUB-Q* Injection

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-325-2016
Class II · Moderate risk

Sermorelin 9 mg/10 mL SUB-Q* Injection

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-324-2016
Class II · Moderate risk

QUAD MIX (30 mg-1 mg-20 mcg-0.16 mg / mL)

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-323-2016
Class II · Moderate risk

Progesterone 100 mg/mL Ethyl Oleate Injection

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-322-2016
Class II · Moderate risk

Progesterone 100 mg/mL in Corn Oil Injection

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-321-2016
Class II · Moderate risk

Progesterone 100 mg/mL IM* Injection in Sesame Oil

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-320-2016
Class II · Moderate risk

MIC Injection

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-319-2016
Class II · Moderate risk

Methylcobalamin 30 mg/mL PF Injection

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-318-2016
Class II · Moderate risk

Methylcobalamin 25 mg/mL PF Injection

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-317-2016
Class II · Moderate risk

Methylcobalamin 20 mg/mL PF Injection

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-316-2016
Class II · Moderate risk

Methylcobalamin 5000 mcg/mL Preservative Free Injection

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-315-2016
Class II · Moderate risk

Methylcobalamin 1 mg/mL

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-314-2016
Class II · Moderate risk

LIPO-B Special Injection

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-313-2016
Class II · Moderate risk

LIPO B Injection

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-312-2016
Class II · Moderate risk

Hcg 10

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-311-2016
Class II · Moderate risk

HCG 5000 Units/mL Injection

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-310-2016
Class II · Moderate risk

HCG 3000 Units/mL Injection

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-309-2016
Class II · Moderate risk

HCG 2000 Units/mL Injection

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-308-2016
Class II · Moderate risk

HCG 1000 U/ LIDO 0.2%/mL Injection

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-307-2016
Class II · Moderate risk

HCG 1000 Units/mL SUB-Q Injection

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-306-2016
Class II · Moderate risk

Glycerin Opth Solution

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-305-2016
Class II · Moderate risk

DUAL TEST CYP/ENA 1:1 200 mg/mL Injection

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-304-2016

Recalls by year